These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker. Spiekermann M; Belge G; Winter N; Ikogho R; Balks T; Bullerdiek J; Dieckmann KP Andrology; 2015 Jan; 3(1):78-84. PubMed ID: 25187505 [TBL] [Abstract][Full Text] [Related]
6. Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA). Klepp O; Flodgren P; Maartman-Moe H; Lindholm CE; Unsgaard B; Teigum H; Fosså SD; Paus E Ann Oncol; 1990 Jul; 1(4):281-8. PubMed ID: 1702312 [TBL] [Abstract][Full Text] [Related]
7. miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy. Rosas Plaza X; van Agthoven T; Meijer C; van Vugt MATM; de Jong S; Gietema JA; Looijenga LHJ Cells; 2019 Oct; 8(10):. PubMed ID: 31597402 [TBL] [Abstract][Full Text] [Related]
13. Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum. Nappi L; Thi M; Lum A; Huntsman D; Eigl BJ; Martin C; O'Neil B; Maughan BL; Chi K; So A; Black PC; Gleave M; Wyatt AW; Lavoie JM; Khalaf D; Bell R; Daneshmand S; Hamilton RJ; Leao RRN; Nichols C; Kollmannsberger C J Clin Oncol; 2019 Nov; 37(33):3090-3098. PubMed ID: 31553692 [TBL] [Abstract][Full Text] [Related]
14. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours. Dieckmann KP; Radtke A; Spiekermann M; Balks T; Matthies C; Becker P; Ruf C; Oing C; Oechsle K; Bokemeyer C; Hammel J; Melchior S; Wosniok W; Belge G Eur Urol; 2017 Feb; 71(2):213-220. PubMed ID: 27495845 [TBL] [Abstract][Full Text] [Related]
15. Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment. Dieckmann KP; Simonsen-Richter H; Kulejewski M; Anheuser P; Zecha H; Isbarn H; Pichlmeier U Biomed Res Int; 2019; 2019():5030349. PubMed ID: 31275973 [TBL] [Abstract][Full Text] [Related]
16. The present and future of serum diagnostic tests for testicular germ cell tumours. Murray MJ; Huddart RA; Coleman N Nat Rev Urol; 2016 Dec; 13(12):715-725. PubMed ID: 27754472 [TBL] [Abstract][Full Text] [Related]
17. Serum estradiol as a tumour marker for non-seminomatous germinal cell tumours (NSGCT) of the testis. Uysal Z; Bakkaloğlu M Int Urol Nephrol; 1987; 19(4):415-8. PubMed ID: 2448261 [TBL] [Abstract][Full Text] [Related]
18. Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors. Nappi L; Thi M; Adra N; Hamilton RJ; Leao R; Lavoie JM; Soleimani M; Eigl BJ; Chi K; Gleave M; So A; Black PC; Bell R; Daneshmand S; Cary C; Masterson T; Einhorn L; Nichols C; Kollmannsberger C Eur Urol; 2021 Jan; 79(1):16-19. PubMed ID: 33158661 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Seelemeyer F; Pfister D; Pappesch R; Merkelbach-Bruse S; Paffenholz P; Heidenreich A Eur Urol Oncol; 2024 Jun; 7(3):319-322. PubMed ID: 37932157 [TBL] [Abstract][Full Text] [Related]
20. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer]. Neumann A; Keller T; Jocham D; Doehn C Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]